Revised SPC: Depakote and Epilim (valproic acid and sodium valproate) products

SPC now notes that although the safety profile in paediatrics is comparable to adults, some reactions are more severe or principally observed in children, e.g. particular increased risk of severe liver damage, pancreatitis, and psychiatric disorders (e.g. aggression).

Source:

electronic Medicines compendium